![Claes Glassell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claes Glassell
Vorsitzender bei
Lyophilization Services of New England, Inc.
Vermögen: 122 427 $ am 31.05.2026
Profil
Claes Johan Robert Glassell currently works at Lyophilization Services of New England, Inc., as Non-Executive Chairman from 2017, QS Pharma LLC, as Non-Executive Chairman, Lyo Lux Holdings, Inc., as Director, Quad UK Topco Ltd., as Director from 2019, and Permira Advisers LLC, as Senior Adviser.
Mr. Glassell also formerly worked at Cerus Corp., as President & Chief Executive Officer from 2004 to 2011, Nordic, as President & Chief Executive Officer, Akzo Nobel, Inc., as President & CEO-Pharma Chemistry Business Area in 2010, Cambrex Karlskoga AB, as President, Chief Executive Officer & Director from 1989 to 1994, Quotient Sciences Ltd., as Non-Executive Chairman from 2019 to 2023, Cambrex Corp., as Executive Director, Vitrolife AB, as Director, AGC Biologics A, as Director from 2005 to 2015, Takara Bio Europe AB, as Director, Cambrex Ltd., as Vice President & Managing Director from 1994 to 2000, Swedish Chemical Industry Association, as Director from 1993 to 1996, The Swedish-American Chamber of Commerce, Inc., as Director, Berol Nobel Ltd., as Director, Nobel Industries AB, as Senior Vice President from 1989 to 1994, and Berol Kemi AB, as Principal.
Mr. Glassell received his graduate degree from Chalmers University of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Kinnevik AB
 Kinnevik AB Financial ConglomeratesFinance Invests in consumer centric businesses 0,01 % | 05.06.2026 | 20 000 ( 0,01 % ) | 122 427 $ | 31.05.2026 |
Aktive Positionen von Claes Glassell
| Unternehmen | Position | Beginn |
|---|---|---|
Lyophilization Services of New England, Inc.
 Lyophilization Services of New England, Inc. Pharmaceuticals: MajorHealth Technology Provides contract lyophilization services to pharmaceutical, biotechnology and medical device industries | Vorsitzender | 01.05.2017 |
Lyo Lux Holdings, Inc.
 Lyo Lux Holdings, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | - |
QS Pharma LLC
 QS Pharma LLC Medical SpecialtiesHealth Technology Provides a broad range of contract research services for pharmaceutical and biopharmaceutical companies | Vorsitzender | - |
Quad UK Topco Ltd.
 Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in research, development and manufacturing of pharmaceutical activities | Direktor/Vorstandsmitglied | 22.10.2019 |
Permira Advisers LLC
 Permira Advisers LLC Investment ManagersFinance Permira Advisers focuses on long-term investments in companies in the following sectors: (1) consumer (2) financial services (3) healthcare (4) industrials and (5) telecommunications, media and technology (TMT). The firm's New York City-based team seeks to generate investment opportunities for the Permira Funds in international companies with significant European operations or the potential for significant European operations. Their Menlo Park, California-based investment team supports Permira Advisers' global TMT team. They focus mainly on the technology sector and are responsible for identifying investment opportunities within the TMT sector for the Permira Funds in North America and globally. In addition, the team works closely with Permira Advisers' New York City-based team to identify investment opportunities in other sectors on the West Coast of the US. | Berater | - |
Ehemalige bekannte Positionen von Claes Glassell
| Unternehmen | Position | Ende |
|---|---|---|
Quotient Sciences Ltd.
 Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Engages in contract research and contract manufacturing of stages of small molecule and synthetic peptide drugs | Vorsitzender | 16.10.2023 |
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Direktor/Vorstandsmitglied | 01.01.2015 |
| CERUS CORPORATION | Vorstandsvorsitzender | 18.04.2011 |
Cambrex Ltd. | Corporate Officer/Principal | 01.01.2000 |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Claes Glassell
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Lyophilization Services of New England, Inc.
Lyophilization Services of New England, Inc. Pharmaceuticals: MajorHealth Technology Provides contract lyophilization services to pharmaceutical, biotechnology and medical device industries | Health Technology |
Vitrolife AB
 Vitrolife AB Medical SpecialtiesHealth Technology Develops, produces and markets products and systems for the preparation, cultivation and preservation of human cells, tissues and organs | Health Technology |
Nobel Industries AB
 Nobel Industries AB Chemicals: Major DiversifiedProcess Industries Manufactures chemicals, paints, and adhesives | Process Industries |
Nordic
 Nordic Other Consumer ServicesConsumer Services Provides business travel, transport management, and financial services | Consumer Services |
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Health Technology |
Akzo Nobel, Inc.
 Akzo Nobel, Inc. Industrial SpecialtiesProcess Industries Manufactures paints and coatings | Process Industries |
QS Pharma LLC
QS Pharma LLC Medical SpecialtiesHealth Technology Provides a broad range of contract research services for pharmaceutical and biopharmaceutical companies | Health Technology |
Cambrex Karlskoga AB
 Cambrex Karlskoga AB Pharmaceuticals: MajorHealth Technology Manufactures specialty chemicals and commodity chemical intermediaries | Health Technology |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Cambrex Ltd. | |
Swedish Chemical Industry Association | |
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Engages in contract research and contract manufacturing of stages of small molecule and synthetic peptide drugs | Health Technology |
Permira Advisers LLC
Permira Advisers LLC Investment ManagersFinance Permira Advisers focuses on long-term investments in companies in the following sectors: (1) consumer (2) financial services (3) healthcare (4) industrials and (5) telecommunications, media and technology (TMT). The firm's New York City-based team seeks to generate investment opportunities for the Permira Funds in international companies with significant European operations or the potential for significant European operations. Their Menlo Park, California-based investment team supports Permira Advisers' global TMT team. They focus mainly on the technology sector and are responsible for identifying investment opportunities within the TMT sector for the Permira Funds in North America and globally. In addition, the team works closely with Permira Advisers' New York City-based team to identify investment opportunities in other sectors on the West Coast of the US. | Finance |
Berol Kemi AB | |
The Swedish-American Chamber of Commerce, Inc.
 The Swedish-American Chamber of Commerce, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a corporation membership organization | Commercial Services |
Lyo Lux Holdings, Inc.
Lyo Lux Holdings, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Berol Nobel Ltd.
 Berol Nobel Ltd. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Quad UK Topco Ltd.
Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in research, development and manufacturing of pharmaceutical activities | Health Technology |
